ClinVar Miner

Submissions for variant NM_003664.5(AP3B1):c.2122_2123delinsTT (p.Glu708Leu)

dbSNP: rs2112260341
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV002008204 SCV002268156 uncertain significance Hermansky-Pudlak syndrome 2 2021-10-20 criteria provided, single submitter clinical testing This sequence change replaces glutamic acid with leucine at codon 708 of the AP3B1 protein (p.Glu708Leu). The glutamic acid residue is weakly conserved and there is a @moderate physicochemical difference between glutamic acid and leucine. The frequency data for this variant in the population databases is not available, as this variant may be reported as separate entries in the ExAC database. This variant has not been reported in the literature in individuals affected with AP3B1-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Not Available"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.